3DDD PHARMA
Dissolution or liquidationSummary
The KBO register records for 3DDD PHARMA the legal situation: dissolution or liquidation; this is today's state according to the register itself, which carries no start date. The 2025 annual accounts show negative equity (-€3.0m) and a net result of -€123.
Signals
This company filed its last 7 accounts on average 44 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Checked, nothing found (2)
History
Financials · fiscal year 2025, full schema
Click a name to add, emphasise or remove a line.
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Other operating charges640/8 | - | €124 | €62 | €62 | €62 | = |
| Gross operating margin9900 | -€1,206 | -€1,752 | -€1,959 | -€1,312 | -€1,418 | ▼ 8.1% |
| Operating profit (loss)9901 | -€1,206 | -€1,876 | -€2,021 | -€1,374 | -€1,480 | ▼ 7.7% |
| Financial income75/76B | - | - | €550 | €1,404 | €1,399 | ▼ 0.4% |
| Recurring financial income75 | - | - | €550 | €1,404 | €1,399 | ▼ 0.4% |
| Financial charges65/66B | €74 | €67 | €114 | €143 | €42 | ▼ 70.6% |
| Recurring financial charges65 | €74 | €67 | €114 | €143 | €42 | ▼ 70.6% |
| Profit (loss) for the period before taxes9903 | -€1,280 | -€1,944 | -€1,585 | -€112 | -€123 | ▼ 9.4% |
| Profit (loss) for the period9904 | -€1,280 | -€1,944 | -€1,585 | -€112 | -€123 | ▼ 9.4% |
| Profit (loss) for the period to be appropriated9905 | -€1,280 | -€1,944 | -€1,585 | -€112 | -€123 | ▼ 9.4% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €693,841 | €691,897 | €690,312 | €690,200 | €690,077 | = |
| Fixed assets21/28 | €3,365 | €3,365 | €3,365 | €3,378 | €3,396 | ▲ 0.5% |
| Financial fixed assets28 | €3,365 | €3,365 | €3,365 | €3,378 | €3,396 | ▲ 0.5% |
| Current assets29/58 | €690,476 | €688,532 | €686,947 | €686,822 | €686,681 | = |
| Amounts receivable within one year40/41 | €7,816 | €7,816 | €7,981 | €10,400 | €9,744 | ▼ 6.3% |
| Other amounts receivable41 | €7,816 | €7,816 | €7,981 | €10,400 | €9,744 | ▼ 6.3% |
| Current investments50/53 | €1 | €1 | €1 | €1 | €1 | = |
| Cash at bank and in hand54/58 | €682,658 | €680,715 | €678,965 | €676,421 | €676,936 | ▲ 0.1% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €693,841 | €691,897 | €690,312 | €690,200 | €690,077 | = |
| Equity10/15 | -€3.0m | -€3.0m | -€3.0m | -€3.0m | -€3.0m | = |
| Contributions10/11 | €1.9m | €1.9m | €1.9m | €1.9m | €1.9m | = |
| Capital10 | €1.9m | €1.9m | €1.9m | €1.9m | €1.9m | = |
| Issued capital100 | €1.9m | €1.9m | €1.9m | €1.9m | €1.9m | = |
| Profit (loss) carried forward14 | -€4.9m | -€4.9m | -€4.9m | -€4.9m | -€4.9m | = |
| Provisions and deferred taxes16 | €377,621 | €377,621 | €377,621 | €377,621 | €377,621 | = |
| Provisions for liabilities and charges160/5 | €377,621 | €377,621 | €377,621 | €377,621 | €377,621 | = |
| Pensions and similar obligations160 | €336,000 | €336,000 | €336,000 | €336,000 | €336,000 | = |
| Other liabilities and charges164/5 | €41,621 | €41,621 | €41,621 | €41,621 | €41,621 | = |
| Amounts payable17/49 | €3.3m | €3.3m | €3.3m | €3.3m | €3.3m | = |
| Amounts payable within one year42/48 | €2.0m | €2.0m | €2.0m | €2.0m | €2.0m | = |
| Trade debts44 | €21,390 | €21,390 | €21,390 | €21,390 | €21,390 | = |
| Suppliers440/4 | €21,390 | €21,390 | €21,390 | €21,390 | €21,390 | = |
| Taxes, remuneration and social security45 | €2.0m | €2.0m | €2.0m | €2.0m | €2.0m | = |
| Taxes450/3 | €2.0m | €2.0m | €2.0m | €2.0m | €2.0m | = |
| Remuneration and social security454/9 | €57,652 | €57,652 | €57,652 | €57,652 | €57,652 | = |
| Accrued charges and deferred income492/3 | €1.3m | €1.3m | €1.3m | €1.3m | €1.3m | = |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€1,280 | -€1,944 | -€1,585 | -€112 | -€123 | ▼ 9.4% |
| Operating cash flow (approximation) | -€1,280 | -€1,944 | -€1,585 | -€112 | -€123 | ▼ 9.4% |
| Investment in fixed assets (approximation) | - | €0 | €0 | -€13 | -€18 | ▼ 36.4% |
| Change in cash | - | -€1,944 | -€1,750 | -€2,544 | €514 | ▲ 120% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
About the unread acts
We know of 12 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Directors · office · real estate
1 establishment unit
1 parcel
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71322A0532/00V004 | Flanders | 7,791 m² | 1 · 4,998 m² | 19.1 m · 5 fl. |
Linked by address, not proof of ownership
Structure & network
Owners and holdings
1 ownerOwners 1
- Sourceaccounts Assimco 202514.99%
Holdings 0
No holding stated in the accounts, acts or LEI register we read.
According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Recognitions · licences · registrations
Food safety, FASFC
1 siteIdentification & contact
No Peppol card under this enterprise or VAT number. That proves nothing: publishing a card is voluntary.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.